CFGS
BVS icon

Concourse Financial Group Securities’s Bioventus BVS Stock Holding History

Concourse Financial Group Securities’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-728
Closed -$7.34K – 280
2024
Q4 		$7.34K Sell
728
-696
-49% -$8.23K ﹤0.01% 1789
2024
Q3 		$17K Buy
+1,424
New +$12.3K ﹤0.01% 1553
2022
Q4 		– Sell
-638
Closed -$2.79K – 2298
2022
Q3 		$4K Buy
638
+73
+13% +$572 ﹤0.01% 1667
2022
Q2 		$4K Buy
+565
New +$5.76K ﹤0.01% 1882

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Concourse Financial Group Securities's BVS Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Bioventus (BVS) in Q1 2025, closing a stake of 728 shares — an estimated $7.34K sold.

Concourse Financial Group Securities first reported a position in BVS in Q2 2022 and held it in 4 quarters. The position peaked at $17K in Q3 2024. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Bioventus position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 728 Bioventus shares in Q1 2025, an estimated $7.34K.
  • Concourse Financial Group Securities first reported a position in Bioventus in Q2 2022 and held it in 4 quarters.
  • Concourse Financial Group Securities's Bioventus position peaked at $17K in Q3 2024.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.